NEW YORK, Nov. 19, 2018 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies […]
Evogene’s activities relating to design and development of effective and safe next generation agro-chemical products transferred to new subsidiary REHOVOT, […]
YONKERS, N.Y., Nov. 19, 2018 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and […]